Congenital Myasthenic Syndrome 1a C2931107
A genetic disorder affecting nerve-muscle communication, causing muscle weakness that typically appears in infancy. Medications can help improve strength in many cases.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Respiratory insufficiency requiring ventilatory support
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Fatigable limb weakness
(neurologic)Ptosis (drooping of eyelids)
(neurologic)Dysphagia (difficulty swallowing)
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Acetylcholinesterase Inhibitors
First-line pharmacological treatment using cholinesterase inhibitors to improve neuromuscular transmission by preventing breakdown of acetylcholine at the synaptic junction.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Potassium Channel Blockers
Adjunctive medication to prolong action potential duration and improve calcium influx, enhancing muscle contraction in some subtypes of congenital myasthenic syndrome.
Additional treatment options
Energy Conservation Techniques
Strategic activity planning and pacing strategies to distribute energy expenditure throughout the day, avoiding prolonged muscle use that triggers fatigue and weakness.
lifestyleGentle Muscle Conditioning Program
Low-intensity, graded exercise program designed to maintain muscle strength without inducing fatigue, focusing on gentle strengthening and breathing exercises.
physical_therapyNeuromuscular Function Monitoring
Regular clinical assessments and potentially electrophysiological studies to track disease progression, treatment response, and identify complications such as respiratory involvement.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Congenital Myasthenic Syndrome 1a C2931107?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Engel AG, Shen XM, Sine S. Congenital myasthenic syndromes: a heterogeneous group of disorders. Neurology. 2020.
Harper CM,optiz DR. Clinical spectrum of congenital myasthenic syndromes. Muscle Nerve. 2019.
Jacobson L, Behere SM. Open-label trial of pyridostigmine in congenital myasthenic syndrome. Ann Neurol. 2021.
Krause S, Wolfertz J. Molecular genetics of CMS: a systematic review. J Neurol. 2018.
Medication Comparisons
Compare medications used to treat Congenital Myasthenic Syndrome 1a C2931107. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy